ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 35 filers reported holding ESSA PHARMA INC in Q3 2023. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $33,721 | -9.1% | 12,489 | 0.0% | 0.00% | – |
| Q1 2023 | $37,092 | +25.5% | 12,489 | +6.5% | 0.00% | – |
| Q4 2022 | $29,555 | +34.3% | 11,728 | -1.2% | 0.00% | – |
| Q3 2022 | $22,000 | -40.5% | 11,868 | +1.7% | 0.00% | – |
| Q2 2022 | $37,000 | -76.0% | 11,669 | -53.2% | 0.00% | – |
| Q1 2022 | $154,000 | -57.6% | 24,944 | -2.4% | 0.00% | – |
| Q4 2021 | $363,000 | +111.0% | 25,559 | +19.1% | 0.00% | – |
| Q3 2021 | $172,000 | -79.2% | 21,457 | -25.9% | 0.00% | – |
| Q2 2021 | $827,000 | +136.3% | 28,957 | +140.2% | 0.00% | – |
| Q1 2021 | $350,000 | – | 12,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 8,748,629 | $15,923,000 | 0.66% |
| Soleus Capital Management, L.P. | 2,640,539 | $4,806,000 | 0.65% |
| Omega Fund Management, LLC | 328,196 | $597,000 | 0.22% |
| MPM BioImpact LLC | 405,700 | $738,000 | 0.18% |
| Bellevue Group AG | 5,898,583 | $10,736,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 375,000 | $1,350,000 | 0.14% |
| PFM Health Sciences, LP | 1,478,252 | $2,690,000 | 0.10% |
| Frazier Life Sciences Management, L.P. | 692,910 | $1,261,000 | 0.10% |
| Avidity Partners Management LP | 2,460,000 | $4,477,000 | 0.09% |
| Eventide Asset Management | 1,561,251 | $2,841,000 | 0.06% |